Astrazeneca (AZN) Goodwill (2009 - 2026)

Astrazeneca's Goodwill history runs 18 years deep, the most recent figure standing at $21.2 billion for Q1 2026.

• In Q1 2026, Goodwill changed 0.3% year-over-year to $21.2 billion; the TTM figure through Mar 2026 stood at $21.2 billion (changed 0.3% YoY), while the FY2025 annual figure was $21.2 billion, up 1.03% from the prior year.
• Goodwill was $21.2 billion for Q1 2026 at Astrazeneca, roughly flat from $21.2 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $21.2 billion in Q4 2025 to a low of -$313.0 million in Q4 2023.
• Historically, Goodwill has averaged $19.3 billion across 5 years, with a median of $20.0 billion in 2023.
• The sharpest annual moves came in 2023 and 2024: Goodwill sank 101.58% in 2023, then jumped 6817.25% in 2024.
• A 5-year view of Goodwill shows it stood at $19.8 billion in 2022, then plunged by 101.58% to -$313.0 million in 2023, then surged by 6817.25% to $21.0 billion in 2024, then gained by 1.03% to $21.2 billion in 2025, then fell by 0.23% to $21.2 billion in 2026.
• The last three Goodwill figures came in at $21.2 billion (Q1 2026), $21.2 billion (Q4 2025), and $21.2 billion (Q3 2025), per Business Quant data.